ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ADCT ADC Therapeutics SA

4.46
0.02 (0.45%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue
Operating Income
Pre Tax Income
Net Income
Preferred Dividends
Basic Earnings Per Share (EPS)
EBIT
EBITDA
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.34M033.92M209.91M69.56M
Operating Income -117.74M-194.9M-268.39M-123.63M-165.99M
Pre Tax Income -115.9M-245.96M-251.51M-154.66M-195.42M
Net Income -116.48M-246.29M-230.03M-155.8M-234.53M
Preferred Dividends 00000
Basic Earnings Per Share (EPS) -2.236-3.208-5.878-1.75-2.85
EBIT -117.74M-194.31M-268.03M-123.63M-165.99M
EBITDA -116.1M-192.71M-265.76M-121.07M-164.8M

Your Recent History

Delayed Upgrade Clock